Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.2.1.17 (
lysozyme
)
21,489
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Since the transcription factor
Zfhep
is expressed in somatotropes and binds the rat growth hormone (rGH) gene T3-response element (TRE), we investigated whether
Zfhep
regulates the response of this gene to T3. In cotransfection experiments,
Zfhep
did not regulate the native rGH promoter in the absence of T3. However,
Zfhep
repressed T3-mediated activation significantly in either GH(3) or JEG-3 cells. Up to 70% repression was mediated through the rGH TRE in a heterologous promoter (thymidine kinase), but was not observed with the idealized DR4 or chicken
lysozyme
F2 TREs.
Zfhep
apparently does not repress T3-mediated activation simply by competition for binding to DNA since the C-terminal DNA-binding domain of
Zfhep
(which is sufficient for DNA-binding) is not sufficient for repression and since cotransfection of excess thyroid hormone receptor (TR) did not prevent repression by
Zfhep
. These data indicate that the rGH TRE is a composite element that can integrate
Zfhep
and T3 regulation.
...
PMID:T3-activation of the rat growth hormone gene is inhibited by a zinc finger/homeodomain protein. 1147 47